Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790241 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
Our results provide preliminary evidence suggesting that SIRT1, SIRT3, and SIRT6 function as tumor suppressors in RCC. In particular, SIRT3 seems to have a favorable influence on the survival of patients with clear cell RCC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Seong Uk M.D., Ph.D., Jung Je M.D., Ph.D., Jong Sil M.D., Ph.D., Dong Chul M.D., Ph.D., Jungmo M.D., Sin Woo M.D., See Min M.D., Ph.D., Jae Seog M.D., Ph.D., Deok Ha M.D., Chunwoo M.D., Ph.D., Sung Chul M.D., Ph.D., Ky Hyun M.D., Ph.D., Jeong Seok M.D.,